Search Page

1

Cite

Share

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.

Disanto G, Barro C, Benkert P, Naegelin Y, Schädelin S, Giardiello A, Zecca C, Blennow K, Zetterberg H, Leppert D, Kappos L, Gobbi C, Kuhle J; Swiss Multiple Sclerosis Cohort Study Group. Disanto G, et al. Ann Neurol. 2017 Jun;81(6):857-870. doi: 10.1002/ana.24954. Ann Neurol. 2017. PMID: 28512753 Free PMC article.

Cite

Share

2

Cite

Share

Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing With Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis.

Disanto G, Sacco R, Bernasconi E, Martinetti G, Keller F, Gobbi C, Zecca C. Disanto G, et al. JAMA Neurol. 2021 Dec 1;78(12):1529-1531. doi: 10.1001/jamaneurol.2021.3609. JAMA Neurol. 2021. PMID: 34554185

Cite

Share

3

Cite

Share

Vitamin D-gene interactions in multiple sclerosis.

Berlanga-Taylor AJ, Disanto G, Ebers GC, Ramagopalan SV. Berlanga-Taylor AJ, et al. Among authors: disanto g. J Neurol Sci. 2011 Dec 15;311(1-2):32-6. doi: 10.1016/j.jns.2011.08.041. Epub 2011 Oct 13. J Neurol Sci. 2011. PMID: 22000399 Review.

Cite

Share

4

Cite

Share

Next-generation sequencing in understanding complex neurological disease.

Handel AE, Disanto G, Ramagopalan SV. Handel AE, et al. Among authors: disanto g. Expert Rev Neurother. 2013 Feb;13(2):215-27. doi: 10.1586/ern.12.165. Expert Rev Neurother. 2013. PMID: 23368808 Free PMC article. Review.

Cite

Share

5

Cite

Share

Multiple sclerosis: risk factors and their interactions.

Disanto G, Morahan JM, Ramagopalan SV. Disanto G, et al. CNS Neurol Disord Drug Targets. 2012 Aug;11(5):545-55. doi: 10.2174/187152712801661266. CNS Neurol Disord Drug Targets. 2012. PMID: 22583442 Review.

Cite

Share

6

Cite

Share

Neurologic complications of acute hepatitis E virus infection.

Ripellino P, Pasi E, Melli G, Staedler C, Fraga M, Moradpour D, Sahli R, Aubert V, Martinetti G, Bihl F, Bernasconi E, Terziroli Beretta-Piccoli B, Cerny A, Dalton HR, Zehnder C, Mathis B, Zecca C, Disanto G, Kaelin-Lang A, Gobbi C. Ripellino P, et al. Among authors: disanto g. Neurol Neuroimmunol Neuroinflamm. 2019 Dec 5;7(1):e643. doi: 10.1212/NXI.0000000000000643. Print 2020 Jan. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31806684 Free PMC article.

Cite

Share

7

Cite

Share

The evidence for a role of B cells in multiple sclerosis.

Disanto G, Morahan JM, Barnett MH, Giovannoni G, Ramagopalan SV. Disanto G, et al. Neurology. 2012 Mar 13;78(11):823-32. doi: 10.1212/WNL.0b013e318249f6f0. Neurology. 2012. PMID: 22411958 Free PMC article. Review.

Cite

Share

8

Cite

Share

Recurrence and Prognostic Value of Asymptomatic Spinal Cord Lesions in Multiple Sclerosis.

Ostini C, Bovis F, Disanto G, Ripellino P, Pravatà E, Sacco R, Padlina G, Sormani MP, Gobbi C, Zecca C. Ostini C, et al. Among authors: disanto g. J Clin Med. 2021 Jan 26;10(3):463. doi: 10.3390/jcm10030463. J Clin Med. 2021. PMID: 33530366 Free PMC article.

Cite

Share

9

Cite

Share

Restless legs syndrome and periodic limb movements in 86 patients with multiple sclerosis.

Sparasci D, Ferri R, Castelnovo A, Miano S, Tanioka K, Tachibana N, Carelli C, Riccitelli G, Disanto G, Zecca C, Gobbi C, Manconi M. Sparasci D, et al. Among authors: disanto g. Sleep. 2021 Sep 13;44(9):zsab066. doi: 10.1093/sleep/zsab066. Sleep. 2021. PMID: 33720378

Cite

Share

10

Cite

Share

Increasing cancer risk over calendar year in people with multiple sclerosis: a case-control study.

Zecca C, Disanto G, Sacco R, MacLachlan S, Kuhle J, Ramagopalan SV, Gobbi C. Zecca C, et al. Among authors: disanto g. J Neurol. 2021 Mar;268(3):817-824. doi: 10.1007/s00415-020-10170-5. Epub 2020 Oct 21. J Neurol. 2021. PMID: 33084939 Free PMC article.

Cite

Share